What will then be the expected EBITDA for FY19? Using 24% of revenue calc approximation, this will probably come in at around $120M EBITDA?
Ann: Mayne Pharma market update, page-2
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.53 |
Change
-0.090(1.95%) |
Mkt cap ! $381.1M | |||
| Open | High | Low | Value | Volume |
| $4.60 | $4.62 | $4.47 | $216.4K | 47.80K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 283 | $4.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.53 | 145 | 4 |
View Market Depth
| Last trade - 14.35pm 08/10/2024 (20 minute delay) ? |
| MYX (ASX) Chart |